top of page

Missouri Mids Brands Threaten to Stop Selling to Dispensaries. Dispensaries Ask Them to Put It in Writing.

11 minutes ago
7 min read

As the DEA's new medical cannabis framework creates confusion across the industry, some brands have discovered a bold negotiating strategy: threatening to take away products nobody was particularly worried about losing.


MISSOURI — In what may be the least effective hostage negotiation in cannabis history, several Missouri cannabis brands have reportedly begun warning dispensaries that they will stop supplying products unless retailers pursue registration under the DEA's new federal medical cannabis framework.


The threats have been met with confusion, disbelief, and, in some cases, what can only be described as overwhelming gratitude.


Because apparently, some of the brands making these demands are the same ones dispensaries have been trying to figure out how to politely discontinue for months.


For years, cannabis retailers have struggled with the delicate process of removing underperforming brands from their shelves without offending the sales representatives who keep showing up with donuts.

Now, thanks to federal regulatory confusion, some of those brands are volunteering to leave.

"Please don't threaten us with a good time."


The DEA Has Accidentally Created the World's Worst Hostage Negotiation.


The DEA's new federal medical cannabis framework has introduced another layer of complexity into an industry already operating under enough regulations to make a nuclear power plant look like a lemonade stand.


Operators are attempting to understand how federal registration affects their existing state licenses, medical cannabis transactions, and relationships with suppliers.


Some brands participating in the federal framework have begun warning dispensaries that continued distribution may depend on the retailer's registration status.


For certain covered transactions, those concerns may reflect legitimate compliance obligations.

But somewhere between federal guidance and the sales department, the message apparently became:


"If you don't apply, we're taking our products away."


A devastating threat.


Assuming, of course, anyone wanted the products.


Imagine a restaurant receiving a call from its least popular appetizer.


"Unless you comply with our new requirements, we're removing ourselves from your menu."


The restaurant pauses.


Looks at the freezer full of unsold jalapeño poppers.


And responds:


"Can you do that by Friday?"


You're Threatening to Take Away WHAT, Exactly?


According to a Missouri dispensary operator dealing with the situation, some of the brands issuing these warnings aren't exactly the products keeping purchasing managers awake at night.


These aren't necessarily the products customers line up for.


They're not the brands generating consistent sell-through.


They're not the products that make customers drive across town.


They're the ones that have been sitting in inventory long enough to qualify for employee benefits.


The brands that need a 30% discount, a vendor day, three Instagram posts, and a personal recommendation from the budtender just to move six eighths.


And now they're threatening to stop selling.


Sir, your flower has been on clearance since the Fourth of July.


This is not the leverage you think it is.


The situation is the cannabis equivalent of a guy threatening to break up with someone who has been trying to figure out how to end the relationship for six months.


"You'll never see me again!"


"Okay, but can I get that in writing?"


Dispensaries Discover the Benefits of Doing Absolutely Nothing.


For years, dispensary purchasing managers have been forced to have uncomfortable conversations with brands about poor sales performance.


It's a painful process.


The sales representative insists the problem is visibility.


The marketing director insists the problem is education.


The CEO insists the problem is brand positioning.


The budtenders insist the problem is that nobody wants to buy the fucking product.


But nobody listens to the budtenders.


Instead, everyone schedules another meeting.


Maybe the brand needs a better shelf position.


Maybe it needs a promotional campaign.


Maybe it needs a vendor activation.


Maybe it needs a completely new packaging design featuring a slightly different shade of black.


Anything except acknowledging the possibility that consumers simply don't give a shit.


Now, thanks to the DEA, those conversations may no longer be necessary.


The brand calls.


The brand threatens to leave.


The dispensary agrees.


Everybody wins.


Except the brand.


Congratulations. You've successfully discontinued yourself.


The Most Polite Breakup in Cannabis History.


Picture the conversation.


Sales Rep: We're going to need confirmation that you've applied for DEA registration.


Dispensary: We haven't.


Sales Rep: Well, unfortunately, we may no longer be able to sell you our products.


Dispensary: Okay.


Sales Rep: I'm not sure you understand the seriousness of this.


Dispensary: No, I understand.


Sales Rep: This could mean losing access to our entire product portfolio.


Dispensary: All of it?


Sales Rep: Yes.


Dispensary: Even the stuff that's been sitting here since March?


Sales Rep: Unfortunately.


Dispensary: Wow.


Sales Rep: We really don't want it to come to this.


Dispensary: Neither do we. But we respect your decision.


Sales Rep: So you'll apply?


Dispensary: No. But could you send the discontinuation notice in writing?


Sales Rep: Why?


Dispensary: Purchasing wants to make sure we don't accidentally reorder anything.


Somewhere, a regional sales manager is preparing a report explaining that the account was lost due to federal regulatory uncertainty.


Not poor sales.


Not declining demand.


Not the fact that the product was outsold by a package of rolling papers.


Federal regulatory uncertainty.


Much more professional.


Cannabis Brands Have Confused Shelf Space With Consumer Demand.


There's a fundamental misunderstanding among certain cannabis brands about how dispensary retail works.


Just because a dispensary carries your product doesn't mean it needs your product.


Sometimes a brand gets shelf space because it offers something genuinely valuable.


Sometimes it has strong consumer demand.


Sometimes it has competitive pricing, consistent quality, and reliable distribution.


And sometimes a purchasing manager agreed to carry it eight months ago because the sales rep wouldn't stop fucking calling.


These are not equivalent business achievements.


Yet the industry has developed an extraordinary talent for confusing distribution with success.


A brand gets into 100 dispensaries and immediately announces a major expansion.


Its CEO posts about explosive growth.


Its marketing team celebrates increased market penetration.


Its investors receive a presentation featuring several upward-pointing arrows.


Meanwhile, 83 of those dispensaries are wondering how to get rid of the inventory.


Being on the shelf is not the same as being taken off the shelf by a customer.


And when a brand that isn't moving threatens to remove itself from distribution, the dispensary isn't necessarily losing an asset.


It might be recovering one.


Shelf space.


Working capital.


Staff attention.


And, perhaps most importantly, the 45 minutes previously spent listening to a sales rep explain why the next batch is going to be different.


The DEA Is Confusing. Your Brand's Importance Shouldn't Be.


To be fair, there is a legitimate regulatory issue underneath this entire circus.


The federal medical cannabis framework has introduced new considerations for businesses pursuing DEA registration, including restrictions affecting certain transactions between participating suppliers and retailers.


Companies attempting to maintain compliance may have valid reasons to reconsider specific distribution relationships.


That's understandable.


What's considerably less understandable is treating those restrictions like a negotiating weapon against dispensaries.


A retailer's decision about federal registration involves legal, financial, and operational considerations.

It's not something that should be determined by whether a slow-moving vape brand threatens to stop delivering its three best-selling flavors.


Especially when the third-best-selling flavor has sold twice this quarter.


If a supplier has a genuine legal concern, explain it.


Provide the relevant requirements.


Identify which transactions are affected.


And let the retailer evaluate its options.


But don't confuse a compliance notification with a power move.


You are not negotiating the release of hostages. You're selling weed.


And apparently not very much of it.


Somewhere, a Cannabis CEO Is Calling This a Strategic Realignment.


The best part of this entire situation is imagining how these conversations will eventually be described in corporate cannabis language.


A brand voluntarily stops supplying a dispensary.


The dispensary accepts.


Nobody panics.


Nobody begs.


Nobody requests an emergency meeting.


And somewhere in a conference room, an executive decides the company has made a bold strategic decision to prioritize federally aligned distribution partnerships.


The marketing department gets involved.


A LinkedIn announcement is drafted.


"Today, we're proud to announce an important evolution in our commitment to responsible cannabis commerce."


There will be references to integrity.


There will be references to leadership.


There will be references to navigating an evolving regulatory landscape.


There may even be a quote from the CEO about making difficult decisions in the best interests of the industry.


Meanwhile, the dispensary's purchasing manager is looking at the email and thinking:


"Holy shit, that was easy."


No markdown negotiations.


No awkward conversations.


No promises to try another vendor day.


The brand simply walked itself out the door.


And called it leadership.


Please Don't Threaten Us With a Good Time.


The cannabis industry has spent years convincing itself that every brand is revolutionary, every product is premium, and every executive decision represents an important milestone in the evolution of the plant.


But the market has a remarkably effective way of cutting through the bullshit.


Consumers either buy your product or they don't.


And if they don't, no amount of thought leadership, proprietary genetics, premium packaging, or federal compliance posturing is going to make a dispensary desperately afraid of losing you.


For genuinely successful brands, changes to distribution relationships can have serious consequences for retailers.


But for underperforming products already occupying valuable shelf space, a supplier-initiated departure might be the most useful contribution the brand has made all year.


So, to the Missouri mids brands threatening to stop selling to dispensaries that haven't pursued DEA registration:


We hear you.


We respect your position.


We understand that these are difficult times.


And we appreciate your commitment to making the hard decisions.


But before you go, we have one final request.


Please put it in writing.


Not because we're worried.


Not because we're reconsidering.


Not because we're calling our attorney.


Because purchasing wants to frame the first vendor email in cannabis history that actually solved an inventory problem.


And if you could arrange to pick up the remaining product on your way out, that would be fucking fantastic.


Comments


bottom of page